Nous sommes auteurs et co-auteurs de nombreuses publications dans des revues médicales et scientifiques à comité de lecture, consultables en ligne sur notre site.
070
Risk factors for severe bacterial infections in patients with systemic autoimmune diseases receiving rituximab.
Heusele M, Clerson P, Guery B, Lambert M, Launay D, Lefevre G, Morell-Dubois S, Maillard H, Le Gouellec N, Hatron PY, Hachulla E.
069
Revisiting comorbidities in gout: a cluster analysis.
Richette P, Clerson P, Périssin L, Flipo RM, Bardin T.
068
Survival in systemic sclerosis-associated pulmonary arterial hypertension in the modern management era.
Launay D, Sitbon O, Hachulla E, Mouthon L, Gressin V, Rottat L, Clerson P, Cordier JF, Simonneau G, Humbert M.
067
Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey.
Cohen Solal A, Leurs I, Assyag P, Beauvais F, Clerson P, Contre C, Thebaut JF, Genoun M; French National College of Cardiologists.
066
Reversal of Vitamin K Antagonist (VKA) effect in patients with severe bleeding: a French multicenter observational study (Optiplex) assessing the use of Prothrombin Complex Concentrate (PCC) in current clinical practice.
Desmettre T, Dehours E, Samama CM, Jhundoo S, Pujeau F, Guillaudin C, Hecquart C, Clerson P, Crave JC, Jaussaud R.
065
Relationship between 25-OH-D serum level and relapse rate in multiple sclerosis patients before and after vitamin D supplementation
Charles Pierrot-Deseilligny, Sophie Rivaud-Péchoux, Pierre Clerson, Raphaël de Paz ,Jean-Claude Souberbielle
064
Could the "Cochin risk prediction score" be applied in daily practice to predict pulmonary hypertension in systemic sclerosis?
Hachulla E, Clerson P, Humbert M.
063
Screening for pulmonary arterial hypertension in patients with systemic sclerosis: Clinical characteristics at diagnosis and long-term survival.
Humbert M, Yaici A, de Groote P, Montani D, Sitbon O, Launay D, Gressin V, Guillevin L, Clerson P, Simonneau G, Hachulla E.
062
A hemodynamic study of pulmonary hypertension in sickle cell disease.
Parent F, Bachir D, Inamo J, Lionnet F, Driss F, Loko G, Habibi A, Bennani S, Savale L, Adnot S, Maitre B, Yaïci A, Hajji L, O'Callaghan DS, Clerson P, Girot R, Galacteros F, Simonneau G.
061
Clinical characteristics and survival in systemic sclerosis-related PH associated With ILD.
Launay D, Humbert M, Berezne A, Cottin V, Allanore Y, Couderc LJ, Bletry O, Yaici A, Hatron PY, Mouthon L, Le Pavec J, Clerson P, Hachulla E.